Barclays Maintains an 'Overweight' on MetLife (MET); Share Buybacks and Strategic Review Offer Potential Upside to EPS, ROE Outlook

Go back to Barclays Maintains an 'Overweight' on MetLife (MET); Share Buybacks and Strategic Review Offer Potential Upside to EPS, ROE Outlook
MetLife Inc. (NYSE: MET) Delayed: 94.34 +0.88 (0.94%)
Previous Close $93.46    52 Week High $55.30 
Open $94.20    52 Week Low $35.00 
Day High $94.91    P/E 16.82 
Day Low $93.93    EPS $5.61 
Volume 4,849,854